PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34481023-0	2021	Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy.	bufalin	15-22	albumin	Homo sapiens	42-49	
34481023-4	2021	Herein, we developed multifunctional albumin sub-microspheres prepared by coaxial-electrospray technology to co-delivery bufalin and nintedanib for tumor-targeted combination therapy.	bufalin	121-128	albumin	Homo sapiens	37-44	
26648168-5	2016	Our results indicate that: i) bufalin can regulate the expression of associated factors in Wnt/beta-catenin signaling pathway of BEL-7402 cells through suppressing the phosphorylation of GSK-3beta Ser9 site; ii) bufalin can strengthen intercellular E-cadherin/beta-catenin complex to control epithelial-mesenchymal transition; and iii) bufalin can reverse the malignant phenotype and promote the differentiation and maturation by regulating the AFP and ALB expression in BEL-7402 cells.	bufalin	30-37	albumin	Homo sapiens	453-456